Elevation Oncology has won Food and Drug Administration fast-track designation for EO-3021, its lead drug candidate, in certain patients with gastrointestinal cancers.
Area residents are accustomed to seeing the Fred & Pamela Buffett Cancer Center name on Omaha's Midtown skyline, but it will soon appear in three additional locations.